These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37551601)

  • 1. l -carnitine adjunct to risperidone for treatment of autism spectrum disorder-associated behaviors: a randomized, double-blind clinical trial.
    Nasiri M; Parmoon Z; Farahmand Y; Moradi A; Farahmand K; Moradi K; Basti FA; Mohammadi MR; Akhondzadeh S
    Int Clin Psychopharmacol; 2024 Jul; 39(4):232-239. PubMed ID: 37551601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Pregnenolone Adjunct to Risperidone Ameliorate Irritable Behavior in Adolescents With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial?
    Ayatollahi A; Bagheri S; Ashraf-Ganjouei A; Moradi K; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(5):139-145. PubMed ID: 32947424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial.
    Hendouei F; Sanjari Moghaddam H; Mohammadi MR; Taslimi N; Rezaei F; Akhondzadeh S
    J Clin Pharm Ther; 2020 Apr; 45(2):324-334. PubMed ID: 31714621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane as an adjunctive treatment for irritability in children with autism spectrum disorder: A randomized, double-blind, placebo-controlled clinical trial.
    Momtazmanesh S; Amirimoghaddam-Yazdi Z; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Psychiatry Clin Neurosci; 2020 Jul; 74(7):398-405. PubMed ID: 32347624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Adding l -Carnitine to Risperidone on Behavioral, Cognitive, Social, and Physical Symptoms in Children and Adolescents With Autism: A Randomized Double-Blinded Placebo-Controlled Clinical Trial.
    Shakibaei F; Jelvani D
    Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):55-59. PubMed ID: 36735565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisolone as Adjunctive Treatment to Risperidone in Children With Regressive Type of Autism Spectrum Disorder: A Randomized, Placebo-Controlled Trial.
    Malek M; Ashraf-Ganjouei A; Moradi K; Bagheri S; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2020; 43(2):39-45. PubMed ID: 32168067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
    Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M; Radnia H; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2015; 38(1):11-7. PubMed ID: 25580916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline as Adjunctive Treatment to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind Placebo-Controlled Trial.
    Ghaleiha A; Alikhani R; Kazemi MR; Mohammadi MR; Mohammadinejad P; Zeinoddini A; Hamedi M; Shahriari M; Keshavarzi Z; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):784-791. PubMed ID: 27128958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.
    Ghanizadeh A; Moghimi-Sarani E
    BMC Psychiatry; 2013 Jul; 13():196. PubMed ID: 23886027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Moazen-Zadeh E; Shirzad F; Karkhaneh-Yousefi MA; Khezri R; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):82-89. PubMed ID: 28719227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial.
    Ebrahimi P; Seyedmirzaei H; Moradi K; Bagheri S; Moeini M; Mohammadi MR; Akhondzadeh S
    Int Clin Psychopharmacol; 2023 Mar; 38(2):89-95. PubMed ID: 36165508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
    Ghaleiha A; Rasa SM; Nikoo M; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Psychiatry Res; 2015 Sep; 229(1-2):181-7. PubMed ID: 26208985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical Antipsychotics for Irritability in Pediatric Autism: A Systematic Review and Network Meta-Analysis.
    Fallah MS; Shaikh MR; Neupane B; Rusiecki D; Bennett TA; Beyene J
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):168-180. PubMed ID: 30707602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial severity and efficacy of risperidone in autism: Results from the RUPP trial.
    Levine SZ; Kodesh A; Goldberg Y; Reichenberg A; Furukawa TA; Kolevzon A; Leucht S
    Eur Psychiatry; 2016 Feb; 32():16-20. PubMed ID: 26802979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial.
    Mahdavinasab SM; Saghazadeh A; Motamed-Gorji N; Vaseghi S; Mohammadi MR; Alichani R; Akhondzadeh S
    Eur Child Adolesc Psychiatry; 2019 Dec; 28(12):1619-1628. PubMed ID: 30980177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.